Research location
Eschwege
Hesse, Germany
Advertisement
Research activity in Eschwege
Hesse, GermanyCureCurrent currently publishes aggregate city-level research activity for this location: 8 trials and 8 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Eschwege
8 linked trials · page 1 of 1Assessment of the Effectiveness, Socio-economic Impact and Implementation of a Digital Solution for Severe PatientsNCT05575336 · 2023-02-01 · 1 site observation
COMPLETED
Dimethyl Fumarate (DMF) Observational StudyNCT02047097 · 2013-11-19 · 1 site observation
COMPLETED
Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and AdolescentsNCT01159912 · 2010-06-30 · 1 site observation
COMPLETED
A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT01053988 · 2009-10-05 · 1 site observation
COMPLETED
Influence Of Salmeterol Xinafoate/Fluticasone Propionate (50/500 µg BID) On The Course Of The Disease And Exacerbation Frequency In COPD Patients Gold Stage III And IVNCT00527826 · 2007-11-01 · 1 site observation
COMPLETED
Results Of Patient Rated Asthma Control Test In Comparison To Diary Card DataNCT00363480 · 2006-05-17 · 1 site observation
COMPLETED
A Study of GW685698X 100mcg Administered Once Daily Either in the Morning or the Evening and GW685698X 250mcg Administered Once Daily in the Evening Via DISKHALER for 28 Days in Subjects With Persistent Bronchial Asthma.NCT01499446 · 2003-09-01 · 1 site observation
COMPLETED
SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary DiseaseNCT00361959 · 2003-06-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.